The diagnosis of PC is expected to be based on a comprehensive consideration of the results from biomarker tests, including apoA2-i and diagnosis imaging tests (e.g., enhanced CT, MRI, and EUS). The gene discussed is APOA2; the disease is pachyonychia congenita.